Drug Delivery - Snapshots and Highlights - Market Research Reports - Research and Markets

Printer Friendly

Printed from http://www.researchandmarkets.com/reports/516921

Drug Delivery - Snapshots and Highlights

Description:

This Frost & Sullivan research service titled Drug Delivery: Snapshots and Highlights provides an insight into the pharmaceutical and biotech sectors and their strategies for new and innovative methods of drug delivery. In this research service, Frost & Sullivan's expert analysts examine the areas of implant delivery, oral modified release, and nanobiotechnology. Also discussed are business strategy trends currently important in drug delivery relative to business development, licensing, and lifecycle management.

Patent Expiries and Generic Competition Increase Focus on Product Lifecycle Management

Drug delivery is an important facet of pharmaceutical product development. Changing a drug’s delivery method can help improve the product’s therapeutic benefits and revenue potential. The prolonged research and clinical evaluation process for drugs reduces the patent life for pharmaceuticals. This pressure compels pharmaceuticals developers to use novel product lifecycle management strategies to maximize revenue and extend IP. Altering a drug’s delivery technology has proven to be an effective strategy.

Continued technology evolution is also vital for drug development and future pharmacotherapy. "Business strategies have increasingly begun to include aspects of drug delivery technologies," notes the analyst of this research service. "Drug delivery companies can potentially enable pharmaceutical companies to revive late stage products by using new drug delivery platforms."

Drug Delivery Sector Continue to Focus on Innovative Methods

"Recent technological advances in drug delivery methods are opening up new avenues for manufacturers," says the analyst. "Marketing a drug with multiple available routes of administration in particular can increase product success." Within the realm of oral delivery, modified release (extended release/controlled release) is expected to bring benefits to companies from both product performance and business standpoints. Another promising technology, nanobiotechnology, is an exciting application for all forms of drug delivery and could have a substantial impact in the way drugs are being manufactured. Implantable drug delivery also has the potential to meet the distinctive therapeutic needs of some patients. Meanwhile, with the predominant indications of pain medications and hormone treatment, transdermal drug delivery has entered a new era with the active and traditional passive patch deliveries.

Overall, pharmaceutical companies now have an increasing amount of choices while determining the most successful route of delivery for their products. With increasing competition and R&D costs, partnerships between pharmaceutical and drug delivery companies are expected to continue to strengthen in the future, as companies seek to deal with issues such as lifecycle management and new product innovation.

Contents:

1. Executive Summary
-1. Executive Summary
--1. Introduction
-2. Drug Delivery Topics
--1. Overview and Scope

2. Snapshots and Highlights
-1. Technology
--1. Implant Technologies: Expected to Remain a Niche but Effective Method of Drug Delivery
--2. Oral Extended Release: Snapshots and Benefits
--3. Oral Controlled Release: Necessity or Compulsion?
--4. Nanobiotechnology: Delivering Revenue and Exciting Promise for the Future
-2. Business and Strategy
--1. Drug Delivery's Increasing Importance to Big Pharma and Specialty Pharma
--2. Drug Delivery is Integral to Lifecycle Strategies

3. Appendix
-1. Decision Support Databases
--1. Number of Biotechnology Companies
--2. Pharmaceutical R&D Expenditure
--3. Pharmaceutical R&D Expenditure As Percentage of Pharmaceutical Market
--4. Total Healthcare Expenditure
--5. Total Population

List of Figures

Chapter 2

Pharmaceuticals Market: Selected ER Product Analysis (U.S.), 2006
Top Specialty Pharmaceutical Companies: Business Model Adoption (U.S.), 2005-2006

Ordering:

Order Online - visit http://www.researchandmarkets.com/reports/516921

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Page 1 of 2
Printed 23/11/2008 16:32:57

Fax Order Form

To place an order via fax simply print this form, fill in the information below and fax the completed form to the number at the bottom of this page. If you have any questions please email help@researchandmarkets.com

Order information

Please verify that the product information is correct and select the format you require.


Product Name:
Drug Delivery - Snapshots and Highlights
Web Address:
http://www.researchandmarkets.com/reports/516921
Office Code:
OCIEHMIONSV

Report formats

Please enter the quantity of the report format you require.

	Format	Quantity	Price
	Electronic (PDF) - Site License		€4,762.00
	Electronic (PDF) - Enterprisewide		€5,953.00
	Electronic and Hard Copy (PDF) - Enterprisewide		€6,349.00 + EUR€ 50.00 Shipping/Handling *
	Electronic and Hard Copy (PDF) - Site License		€5,159.00 + EUR€ 50.00 Shipping/Handling *

* Shipping/Handling is only charged once per order.

Contact information

Please enter all the information below in BLOCK CAPITALS.


	First Name:	Last Name:
	Email Address:
	Job Title:
	Organisation:
	Address:
	City:
	Postal/Zip Code:
	Country:
	Phone Number:
	Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World

Page 2 of 2
Printed 23/11/2008 16:32:57

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

	American Express
	Diners Club
	Master Card
	Visa


Cardholder Name:

Expiry Date:	/

Card Number:

CVV Security Code:

Issue Date:	/ (Diners Club only)

Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Pay by Wire Transfer:

Please transfer funds to:


Account number:	83313083
Sort code:	98-53-30
Swift code:	ULSBIE2D
IBAN number:	IE78ULSB98533083313083
Bank Address:	Ulster Bank, 27-35 Main St, Blackrock, Co. Dublin, Ireland.

If you have a Marketing Code please enter it below:
	Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World